Hyperimmunoglobulin e syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities

Journal of Research in Medical Sciences

Volumn 22, Issue 1, 2017, Pages

  Hashemi, Hassan ^a,b   Mohebbi, Masoumeh ^a,b   Mehravaran, Shiva ^a,c   Mazloumi, Mehdi ^b   Ardakani, Hamidreza Jahanbani ^d,e   Abtahi, Seyed Hossein ^d,e  

^a NOOR EYE HOSPITAL   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c JULES STEIN EYE INSTITUTE   (United States)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmune disease; Eye; Hyperimmunoglobulin E syndrome; Immunodeficiency; Ocular; Omalizumab; Staphylococcus aureus

Indexed keywords

COMPLEMENT COMPONENT C3B; CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; OMALIZUMAB; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHALAZIA; CONJUNCTIVITIS; CORNEA PERFORATION; EYE DISEASE; EYELID TUMOR; HUMAN; HYPER IGE SYNDROME; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; KERATITIS; KERATOCONUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STRABISMUS; TH1 TH2 BALANCE; XANTHELASMA;

EID: 85018682238     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: 10.4103/jrms.JRMS_1050_16     Document Type: Review

References (92)

1. Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999; 65:735-44.
2. DeWitt CA, Bishop AB, Buescher LS, Stone SP. Hyperimmunoglobulin E syndrome: Two cases and a review of the literature. J Am Acad Dermatol 2006; 54:855-65.
3. Mogensen TH. STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. JAKSTAT 2013; 2:e23435.
4. Joshi AY, Iyer VN, Hagan JB, St. Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: A population-based cohort study. Mayo Clin Proc 2009; 84:16-22.
5. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections – An autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692-702.
6. Chehimi J, Elder M, Greene J, Noroski L, Stiehm ER, Winkelstein JA, et al. Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin Immunol 2001; 100:49-56.
7. Davis SD, Schaller J, Wedgwood RJ. Job’s Syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet 1966; 1:1013-5.
8. Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR. The face of Job. J Pediatr 1998; 133:303-5.
9. Davis S, Schaller J, Wedgwood R. Job’s syndrome with recurrent infection: A review of current opinion and treatment. Lancet 1966; 1:1013-5.
10. Buckley RH, Wray BB, Belmaker EZ. Extreme hyper immune globulinemia E and undue susceptibility to infection. Pediatrics 1972; 49:59-70.
11. Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev 2005; 203:244-50.
12. Hill HR, Quie PG. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974; 1:183-7.
13. Belohradsky BH, Däumling S, Kiess W, Griscelli C. The hyper-IgE-syndrome (Buckley-or Job-syndrome). Ergeb Inn Med Kinderheilkd 1987; 55:1-39.
14. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors. Rheumatol Int 2011; 31:1409-17.
15. Grimbacher B, Belohradsky BH, Holland SM. Immunoglobulin E in primary immunodeficiency diseases. Allergy 2002; 57:995-1007.
16. Eberting CL, Davis J, Puck JM, Holland SM, Turner ML. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol 2004; 140:1119-25.
17. Chamlin SL, McCalmont TH, Cunningham BB, Esterly NB, Lai CH, Mallory SB, et al. Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr 2002; 141:572-5.
18. Alberti-Flor JJ, Granda A. Ileocecal histoplasmosis mimicking Crohn’s disease in a patient with Job’s syndrome. Digestion 1986; 33:176-80.
19. Shemer A, Weiss G, Confino Y, Trau H. The hyper-IgE syndrome. Two cases and review of the literature. Int J Dermatol 2001; 40:622-8.
20. Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: A distinct disease entity. J Pediatr 2004; 144:93-9.
21. Netea MG, Kullberg BJ, van der Meer JW. Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome. Eur J Clin Invest 2005; 35:718-21.
22. Jeppson JD, Jaffe HS, Hill HR. Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections. J Pediatr 1991; 118:383-7.
23. Borges WG, Augustine NH, Hill HR. Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr 2000; 136:176-80.
24. Netea MG, Schneeberger PM, de Vries E, Kullberg BJ, van der Meer JW, Koolen MI. Th1/Th2 cytokine imbalance in a family with hyper-IgE syndrome. Neth J Med 2002; 60:349-53.
25. Metin A, Uysal G, Güven A, Unlu A, Oztürk MH. Tuberculous brain abscess in a patient with hyper IgE syndrome. Pediatr Int 2004; 46:97-100.
26. Ito R, Mori M, Katakura S, Kobayashi N, Naruto T, Osamura Y, et al. Selective insufficiency of IFN-gamma secretion in patients with hyper-IgE syndrome. Allergy 2003; 58:329-36.
27. Petrak B, Augustine N, Hill H, editors. Recombinant human interferon-gamma treatment of patients with jobs syndrome of hyperimmunoglobulin-E and recurrent infections. Clinical Research. Thorofare, NJ: Slack Inc.; 1994.
28. Aihara Y, Mori M, Katakura S, Yokota S. Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia. J Interferon Cytokine Res 1998; 18:561-3.
29. Ohga S, Nomura A, Ihara K, Takahata Y, Suga N, Akeda H, et al. Cytokine imbalance in hyper-IgE syndrome: Reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells. Br J Haematol 2003; 121:324-31.
30. White LR, Iannetta A, Kaplan EL, Davis SD, Wedgwood RJ. Leucocytes in Job’s syndrome. Lancet 1969; 1:630.
31. Gaither TA, Gallin JI, Iida K, Nussenzweig V, Frank MM. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job’s) syndrome. Inflammation 1984; 8:429-44.
32. Gudmundsson KO, Sigurjonsson OE, Gudmundsson S, Goldblatt D, Weemaes CM, Haraldsson A. Increased expression of interleukin-13 but not interleukin-4 in CD4 cells from patients with the hyper-IgE syndrome. Clin Exp Immunol 2002; 128:532-7.
33. Frost A, Jonsson KB, Brändström H, Ohlsson C, Ljunghall S, Ljunggren O. Interleukin-13 inhibits cell proliferation and stimulates interleukin-6 formation in isolated human osteoblasts. J Clin Endocrinol Metab 1998; 83:3285-9.
34. Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 2000; 25:1303-5.
35. Leung DY, Key L, Steinberg JJ, Young MC, Von Deck M, Wilkinson R, et al. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J Immunol 1988; 140:84-8.
36. Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008; 129:448-54.
37. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H) 17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-6.
38. Befus D, Bienenstock J. Factors involved in symbiosis and host resistance at the mucosa-parasite interface. Prog Allergy 1982; 31:76-177.
39. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
40. Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 2004; 173:3482-91.
41. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002; 99:2694-702.
42. Yamazaki-Nakashimada M, Zaltzman-Girshevich S, Garcia de la Puente S, De Leon-Bojorge B, Espinosa-Padilla S, Saez-de-Ocariz M, et al. Hyper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol 2006; 21:1200-5.
43. North J, Kotecha S, Houtman P, Whaley K. Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol 1997; 36:297-8.
44. Freeman AF, Holland SM. Clinical manifestations of hyper IgE syndromes. Dis Markers 2010; 29:123-30.
45. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608-19.
46. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058-62.
47. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208:1635-48.
48. Minegishi Y, Saito M. Cutaneous manifestations of Hyper IgE syndrome. Allergol Int 2012; 61:191-6.
49. Buckley RH. Disorders of the IgE system. Immunological Disorders in Infants and Children. Stiehm ER Philadelphia: Saunders. 1996:409-22.
50. Church JA, Frenkel LD, Wright DG, Bellanti JA. T lymphocyte dysfunction, hyperimmunoglobulinemia E, recurrent bacterial infections, and defective neutrophil chemotaxis in a Negro child. J Pediatr 1976; 88:982-5.
51. Desai K, Huston DP, Harriman GR. Previously undiagnosed hyper-IgE syndrome in an adult with multiple systemic fungal infections. J Allergy Clin Immunol 1996; 98(6 Pt 1):1123-4.
52. Hwang EH, Oh JT, Han SJ, Kim H. Colon perforation in hyperimmunoglobulin E syndrome. J Pediatr Surg 1998; 33:1420-2.
53. Yilmaz E. Disseminated pulmonary candidiasis complicating hyperimmunoglobulin E (Job’s) syndrome. J Thorac Imaging 2004; 19:48-51.
54. Pasic S. Local Bacillus Calmette-Guérin infection in hyperimmunoglobulin-E syndrome. Acta Paediatr 2002; 91:1271-2.
55. Yates AB, Mehrotra D, Moffitt JE. Candida endocarditis in a child with hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol 1997; 99 (6 Pt 1):770-2.
56. Chakrabarti A, Marhawa RK, Mondal R, Trehan A, Gupta S, Rao Raman DS, et al. Generalized lymphadenopathy caused by Trichosporon asahii in a patient with Job’s syndrome. Med Mycol 2002; 40:83-6.
57. Hershko K, Hershko AY, Leibovici V, Meir K, Ingber A. Herpes simplex virus infection in a hyper-IgE patient: Appearance of unusual mass lesions. Acta Derm Venereol 2002; 82:204-5.
58. Höger PH, Boltshauser E, Hitzig WH. Craniosynostosis in hyper-IgE-syndrome. Eur J Pediatr 1985; 144:414-7.
59. Smithwick EM, Finelt M, Pahwa S, Good RA, Naspitz CK, Mendes NF, et al. Cranial synostosis in Job’s syndrome. Lancet 1978; 1:826.
60. Brestel EP, Klingberg WG, Veltri RW, Dorn JS. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136:774-6.
61. O’Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin JI, et al. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:177-85.
62. Crama N, Toolens AM, van der Meer JW, Cruysberg JR. Giant chalazia in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. Eur J Ophthalmol 2004; 14:258-60.
63. Orhan M, Ozkan Y, Irkeç M. Eye involvement in hyperimmunoglobulinemia E (Job’s) syndrome. J Pediatr Ophthalmol Strabismus 2001; 38:313-4.
64. Min JK, Cho ML, Kim SC, Lee YS, Lee SH, Park SH, et al. Hyperimmunoglobulin E-recurrent infection syndrome in a patient with juvenile dermatomyositis. Korean J Intern Med 1999; 14:95-8.
65. Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, et al. The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome. Scand J Infect Dis 2006; 38:898-903.
66. Ozgur TT, Asal GT, Gurgey A, Tezcan I, Ersoy F, Sanal O. Acquired factor VIII deficiency associated with a novel primary immunodeficiency suggestive of autosomal recessive hyper IgE syndrome. J Pediatr Hematol Oncol 2007; 29:327-9.
67. Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, et al. Non-Hodgkin’s lymphoma in Job’s syndrome: A case report and literature review. Leuk Lymphoma 2004; 45:2521-5.
68. Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT. Burkitt’s lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol 1989; 83:5-10.
69. Tanji C, Yorioka N, Kanahara K, Naito T, Oda H, Ishikawa K, et al. Hyperimmunoglobulin E syndrome associated with nephrotic syndrome. Intern Med 1999; 38:491-4.
70. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007; 119:1234-40.
71. Antoniades K, Hatzistilianou M, Pitsavas G, Agouridaki C, Athanassiadou F. Co-existence of Dubowitz and hyper-IgE syndromes: A case report. Eur J Pediatr 1996; 155:390-2.
72. Boeck A, Gfatter R, Braun F, Fritz B. Pentasomy X and hyper IgE syndrome: Co-existence of two distinct genetic disorders. Eur J Pediatr 1999; 158:723-6.
73. Boeck A, Kosan C, Ciznar P, Kunz J. Saethre-Chotzen syndrome and hyper IgE syndrome in a patient with a novel 11 bp deletion of the TWIST gene. Am J Med Genet 2001; 104:53-6.
74. Berger M, Kirkpatrick CH, Goldsmith PK, Gallin JI. IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol 1980; 125:2437-43.
75. Dreskin SC, Goldsmith PK, Strober W, Zech LA, Gallin JI. Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J Clin Invest 1987; 79:1764-72.
76. Geha RS, Reinherz E, Leung D, McKee KT Jr., Schlossman S, Rosen FS. Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest 1981; 68:783-91.
77. Sato E, Yamamoto H, Honda T, Koyama S, Kubo K, Sediguchi M. Acute respiratory distress syndrome due to methicillin-resistant Staphylococcus aureus sepsis in hyper-IgE syndrome. Eur Respir J 1996; 9:386-8.
78. Donabedian H, Alling DW, Gallin JI. Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent-infection (Job’s) syndrome. N Engl J Med 1982; 307:290-2.
79. Hattori K, Hasui M, Masuda K, Masuda M, Ogino H, Kobayashi Y. Successful trimethoprim-sulfamethoxazole therapy in a patient with hyperimmunoglobulin E syndrome. Acta Paediatr 1993; 82:324-6.
80. Friedenberg WR, Marx JJ Jr., Hansen RL, Haselby RC. Hyperimmunoglobulin E syndrome: Response to transfer factor and ascorbic acid therapy. Clin Immunol Immunopathol 1979; 12:132-42.
81. Mawhinney H, Killen M, Fleming WA, Roy AD. The hyperimmunoglobulin E syndrome – a neutrophil chemotactic defect reversible by histamine H2 receptor blockade? Clin Immunol Immunopathol 1980; 17:483-91.
82. Yokota S, Mitsuda T, Shimizu H, Ibe M, Matsuyama S. Cromoglycate treatment of patient with hyperimmunoglobulinaemia E syndrome. Lancet 1990; 335:857-8.
83. Shuttleworth D, Holt PJ, Mathews N. Hyperimmunoglobulin E syndrome: Treatment with isotretinoin. Br J Dermatol 1988; 119:93-9.
84. Kojima K, Inoue Y, Katayama Y, Kataoka M, Sunami K, Fukuda S, et al. Improvement with disodium cromoglycate of neutrophil phagocytosis and respiratory burst activity in a patient with hyperimmunoglobulin E syndrome. Allergy 1998; 53:1101-3.
85. Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S. Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol 1997; 78:413-4.
86. Wolach B, Eliakim A, Pomeranz A, Cohen AH, Nusbacher J, Metzker A. Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 1996; 347:67.
87. Kimata H. High dose gammaglobulin treatment for atopic dermatitis. Arch Dis Child 1994; 70:335-6.
88. Ishikawa I, Fukuda Y, Kitada H, Yuri T, Shinoda A, Hayakawa Y, et al. Plasma exchange in a patient with hyper-IgE syndrome. Ann Allergy 1982; 49:295-7.
89. King CL, Gallin JI, Malech HL, Abramson SL, Nutman TB. Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A 1989; 86:10085-9.
90. Souillet G, Rousset F, de Vries JE. Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet 1989; 1:1384.
91. Casale TB. Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis. Am J Respir Crit Care Med 2001; 164 (8 Pt 2):S18-21.
92. Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001; 108:E36.